Erythrocytosis on TRT
Medically reviewed by Evan Fox, NP
Last updated August 2026
Erythrocytosis is the most common lab abnormality that shows up in men on testosterone therapy. If you are researching TRT and doing it properly, this is a topic you should understand before you start rather than after.
The short version is that testosterone stimulates red blood cell production. In some men, that effect is modest. In others, it pushes hematocrit high enough to require action. It is predictable, detectable on a routine blood count, and manageable when someone is actually looking for it.
The risk is not really the physiology. The risk is being on testosterone without monitoring. A man who injects testosterone from an unsupervised source and never has a CBC drawn can develop significantly elevated hematocrit and have no idea, because the early stages often produce no symptoms at all.
This guide covers why it happens, who is more likely to develop it, what the thresholds are, and how it gets handled.
Quick Answer
Erythrocytosis means an elevated concentration of red blood cells in your blood. On TRT it is measured primarily through hematocrit, the percentage of your blood volume made up of red cells.
Testosterone stimulates erythropoiesis, the production of red blood cells, partly by increasing erythropoietin and partly by improving iron availability. Higher red cell concentration increases blood viscosity.
Typical thresholds used in practice:
- Normal male hematocrit generally sits around 40 to 52 percent
- Most providers watch closely above 52 percent
- Most providers intervene at or above 54 percent
How it is managed: dose reduction, changing to more frequent smaller doses, switching delivery method, therapeutic phlebotomy or blood donation, addressing contributing factors such as sleep apnea, smoking, and dehydration, and in some cases pausing therapy.
How it is prevented: baseline CBC before starting, repeat testing at three and six months, then at least annually, with more frequent checks in higher risk men.
Do not attempt to manage elevated hematocrit yourself. Repeated unsupervised blood donation can create iron deficiency and mask the underlying issue.
What Is Erythrocytosis?
Erythrocytosis is an increase in the concentration of red blood cells. Three related markers appear on your complete blood count:
- Hematocrit (HCT). The percentage of blood volume occupied by red cells. This is the number most used in TRT monitoring.
- Hemoglobin (HGB). The oxygen-carrying protein inside red cells.
- Red blood cell count (RBC). The number of cells per volume.
These usually move together. Hematocrit is the practical monitoring number.
Erythrocytosis versus polycythemia. The terms are often used interchangeably, and on TRT you will see both. Strictly, polycythemia vera is a distinct bone marrow disorder involving a JAK2 mutation and uncontrolled cell production. Secondary erythrocytosis, which is what happens on TRT, is an appropriate marrow response to an external stimulus. They are different conditions with different implications, though the monitoring number is the same.
Why elevated hematocrit matters. Blood is a fluid, and its thickness depends on how much solid material is suspended in it. As red cell concentration rises, viscosity rises with it. Thicker blood moves less efficiently through small vessels. The clinical concern is an increased risk of thrombotic events, meaning clots. The relationship between moderately elevated hematocrit on TRT and actual cardiovascular events is still debated in the literature, and the evidence is not as clear-cut as it is sometimes presented. What is not debated is that hematocrit should be measured and kept within a reasonable range.
Why Testosterone Therapy Can Increase Red Blood Cell Production
Several mechanisms operate together.
Increased erythropoietin. Testosterone raises EPO, the kidney-produced hormone that instructs bone marrow to make red blood cells. Interestingly, testosterone also appears to reset the feedback point at which EPO is suppressed, so production continues at a higher red cell mass than it otherwise would.
Suppression of hepcidin. Hepcidin is the hormone that limits how much iron your body absorbs and releases from storage. Testosterone lowers hepcidin, which increases iron availability. More available iron means more raw material for red cell production.
Direct marrow stimulation. Testosterone appears to act directly on bone marrow progenitor cells that develop into red blood cells.
Delivery method matters. Injectable testosterone, particularly at longer intervals with larger doses, produces the highest rates of erythrocytosis. The peaks after each injection appear to drive the effect. Topical gels and creams, which produce steadier levels without large peaks, are associated with lower rates. This is one of the main practical levers a provider has, and it is why many men who develop elevated hematocrit on a weekly injection do better on twice-weekly smaller injections at the same total dose.
Dose matters. Higher doses and higher resulting testosterone levels correlate with greater increases in hematocrit. This is one of several reasons that supraphysiologic dosing is a poor idea.
Risk Factors for Elevated Hematocrit
Some men are considerably more likely to develop erythrocytosis than others.
Age. Older men on TRT show higher rates.
Injectable testosterone at long intervals. Large doses every two or three weeks produce the sharpest peaks.
Higher doses. Straightforward dose-response relationship.
Untreated obstructive sleep apnea. This is one of the most important and most overlooked factors. Sleep apnea causes repeated overnight oxygen desaturation, which independently stimulates red cell production. Combine it with testosterone and the effect compounds. Many men with troublesome hematocrit on TRT have undiagnosed sleep apnea driving half the problem. If your hematocrit runs high, sleep apnea should be evaluated.
Smoking. Carbon monoxide reduces oxygen-carrying capacity, prompting compensatory red cell production.
Chronic lung disease. COPD and other conditions causing low blood oxygen have the same effect.
Living at altitude. Relevant across much of Nevada. Lower oxygen availability at elevation increases baseline red cell production. A man in Reno or Carson City starts from a higher baseline than a man at sea level, which means less headroom before thresholds are reached.
Dehydration. Worth noting separately because it can produce a falsely elevated reading. Hematocrit is a concentration, so reduced plasma volume raises the percentage without any change in actual red cell mass. A dehydrated draw can overstate the picture, which is why an isolated high result is usually rechecked under better conditions.
Baseline hematocrit at the higher end. Starting at 50 percent leaves less room than starting at 43 percent.
Signs and Symptoms to Watch For
The important thing to understand is that mild to moderate erythrocytosis usually produces no symptoms whatsoever. This is precisely why routine bloodwork is not optional on TRT. By the time you feel something, the number has often been climbing for a while.
When symptoms do occur, they can include:
- Headaches, sometimes persistent
- Flushed or reddened complexion
- Dizziness or lightheadedness
- Fatigue, which is easy to misattribute
- Blurred vision
- Tingling or numbness in hands or feet
- Itching, particularly after a hot shower
- Shortness of breath
- High blood pressure
Seek immediate medical attention for symptoms that could indicate a clot: chest pain, sudden shortness of breath, one-sided weakness or numbness, difficulty speaking, sudden severe headache, or pain and swelling in one leg. These are emergency symptoms regardless of cause.
How Hematocrit Is Monitored During TRT
A reasonable monitoring schedule looks like this.
Before starting. Baseline complete blood count. This establishes your starting point and identifies anyone who should not begin therapy without further evaluation.
Three months in. Follow-up CBC alongside testosterone and other markers. Most treatment-related increases become visible within the first few months.
Six months in. Repeat.
Twelve months, then at least annually. Ongoing surveillance for as long as you remain on therapy.
More frequently if indicated. Men with a rising trend, higher baseline, sleep apnea, or those at altitude may be checked every three to six months indefinitely.
Alongside hematocrit, a proper follow-up panel includes total and free testosterone, PSA where age-appropriate, and a metabolic panel. Iron studies and ferritin become relevant if phlebotomy is being used repeatedly.
Practical testing conditions. Be well hydrated. Test at a consistent time of day. Note recent altitude exposure or illness. Use the same lab where possible so results are comparable.
A rising trend matters as much as an absolute number. A man moving from 45 to 49 to 52 percent across three draws needs a plan even though he has not crossed a threshold yet. Watching the direction of travel is better care than waiting for a line to be crossed.
When Elevated Hematocrit Becomes a Concern
There is no single universally agreed cut-off, and different bodies use slightly different figures.
The commonly used framework in practice:
| Hematocrit | Typical Interpretation | Usual Response |
|---|---|---|
| Below 50% | Within expected range | Continue routine monitoring |
| 50 to 52% | Upper end, watch the trend | Recheck sooner, review hydration and risk factors |
| 52 to 54% | Elevated | Treat the underlying cause |
| 54% and above | Threshold for intervention | Reduce or hold dose, consider phlebotomy, full evaluation |
Above 54 percent is where most guidance recommends active intervention rather than observation.
Additional factors that lower the threshold for action: existing cardiovascular disease, history of blood clots, a clotting disorder, high blood pressure, or symptoms.
A single high result is not automatically a diagnosis. Dehydration, a recent illness, a recent trip to high altitude, or a draw taken immediately after intense exercise can all inflate the reading. Standard practice is to recheck under controlled conditions before making a major change. What matters is a confirmed and sustained elevation.
Treatment and Management Options
Elevated hematocrit is a manageable finding. Rarely does it mean stopping testosterone permanently.
Dose reduction. Often the first and most effective step. Lower testosterone exposure means less stimulation of red cell production. Many men maintain good symptom control at a lower dose than they assumed they needed.
More frequent, smaller injections. Splitting a weekly dose into two smaller injections, or moving to more frequent subcutaneous dosing, reduces the peaks that appear to drive the effect. Same weekly total, different curve, often meaningfully lower hematocrit.
Switching delivery method. Moving from injections to a topical gel or cream produces steadier levels and is associated with lower rates of erythrocytosis. A reasonable option for men who repeatedly run high on injections.
Therapeutic phlebotomy. Removing a unit of blood directly reduces red cell mass. Effective and fast. It should be done under provider direction with iron studies monitored, because repeated phlebotomy depletes iron and can create a separate problem. It also treats the number rather than the cause, so it works best combined with a protocol change.
Blood donation. For men who are eligible, standard donation achieves a similar effect and is useful. Eligibility rules vary, so check with the donation center. Do not use donation as a substitute for monitoring, and do not donate on a self-directed schedule to chase a number.
Address contributing factors. This is where durable improvement usually comes from:
- Evaluate and treat sleep apnea. Frequently the largest single lever.
- Stop smoking.
- Maintain proper hydration.
- Manage blood pressure.
- Reduce alcohol intake.
Pause therapy. If hematocrit is significantly elevated and does not respond to adjustment, holding testosterone until levels normalize is appropriate. Hematocrit typically falls back over a period of weeks to months once the stimulus is removed.
Further evaluation. If hematocrit remains high after testosterone is reduced or stopped, or if other blood counts are abnormal, referral to hematology is warranted to rule out polycythemia vera or another underlying cause.
Preventing Erythrocytosis During TRT
Prevention is mostly a matter of how therapy is designed and followed.
Start with a baseline CBC. Non-negotiable. You cannot interpret a later result without knowing where you began.
Use the lowest effective dose. The goal of TRT is restoring healthy physiologic levels and resolving symptoms. Pushing levels above the normal range increases erythrocytosis risk, along with other risks, and does not produce proportionally better outcomes.
Choose a dosing frequency that avoids large peaks. Twice-weekly or more frequent smaller doses generally produce steadier levels than a single large injection every two weeks.
Screen for sleep apnea before or early in treatment. Particularly if you snore, wake unrefreshed, have a larger neck circumference, or carry excess weight. Treating apnea helps hematocrit, testosterone, energy, and cardiovascular health simultaneously.
Stay hydrated. Simple, and it affects both your true physiology and the accuracy of your readings.
Do not smoke. Compounds directly with testosterone’s effect on red cell production.
Keep up with your labs. This is the whole ballgame. Erythrocytosis is easy to manage when caught at 52 percent and much more disruptive when found at 58 percent after two years without testing.
Account for altitude. If you live in Reno, Carson City, or elsewhere at elevation in Nevada, your baseline runs higher. Your provider should factor this into your monitoring plan rather than applying sea-level assumptions.
Work with a provider who follows you. Any clinic willing to prescribe testosterone without a monitoring schedule is not managing your health. At Men’s Health Co., ongoing labs are part of the protocol, not an upsell.
Frequently Asked Questions
Does TRT always cause high hematocrit?
No. Many men on properly dosed, well-monitored therapy never approach concerning levels. Risk rises with higher doses, longer injection intervals, older age, sleep apnea, smoking, and altitude.
What hematocrit level is dangerous on TRT?
Most guidance treats 54 percent as the threshold for active intervention, with closer attention from 52 percent. Men with cardiovascular disease, a history of clots, or symptoms may have action taken at lower levels.
Can I just donate blood to fix it?
Donation lowers hematocrit, but it should be directed by your provider with iron levels monitored. Self-directed repeated donation risks iron deficiency and leaves the underlying driver unaddressed.
How often should I check my hematocrit on TRT?
Baseline before starting, then at three months, six months, twelve months, and at least annually after that. More frequently if your levels run high or you have risk factors.
Will switching from injections to a gel help?
Often yes. Topical delivery produces steadier levels without large post-injection peaks and is associated with lower rates of erythrocytosis. Whether it suits you depends on absorption, convenience, and transfer precautions.
Does erythrocytosis cause symptoms?
Frequently not, especially at mild to moderate elevations. When symptoms appear they can include headaches, facial flushing, dizziness, blurred vision, and itching after hot showers.
Is erythrocytosis on TRT reversible?
Yes, in the great majority of cases. Reducing the dose, changing the protocol, or pausing therapy allows hematocrit to fall back over weeks to months.
Does drinking more water lower hematocrit?
Hydration prevents falsely elevated readings caused by reduced plasma volume, and it is worth doing. It does not reduce actual red cell mass, so it is not a treatment for genuine erythrocytosis.
Can I keep taking TRT if my hematocrit is high?
Usually yes, with adjustments. Most men continue therapy at a modified dose or schedule with closer monitoring. Stopping permanently is uncommon and is reserved for cases that do not respond.
Does living at altitude affect my TRT monitoring?
Yes. Higher elevation increases baseline red cell production, so men in Reno and elsewhere in Nevada often start from a higher hematocrit. Your provider should account for this rather than applying a sea-level baseline.
What is the difference between erythrocytosis and polycythemia vera?
Erythrocytosis on TRT is a secondary, expected response to an external stimulus and resolves when the stimulus is reduced. Polycythemia vera is a bone marrow disorder involving a genetic mutation and requires hematology management. Persistent elevation after stopping testosterone should prompt evaluation for the latter.
Should I take aspirin if my hematocrit is high?
Do not start aspirin on your own. Aspirin carries bleeding risk and is appropriate only when a provider determines your individual risk profile warrants it. Raise it during your consultation rather than acting independently.
TRT Should Come With Monitoring. Ours Does.
Elevated hematocrit is manageable when someone is watching for it. That is the difference between supervised therapy and a prescription with no follow-up.
Men’s Health Co. is a Nevada-licensed men’s hormone practice in Reno, serving men statewide by telehealth. Baseline labs, scheduled follow-up bloodwork, and protocol adjustments based on your results are built into how we work.
Call (775) 540-2100 | Reno, NV | Statewide telehealth